This limitation may be attributed to the unreliability of PSA and GS scores in measuring tumor behavior, as well as the susceptibility of PSA measurements to external influences such as prostatitis, age, endocrine, or metabolic disorders. The gene discussed is KLK3; the disease is urogenital neoplasm.